✦ LIBER ✦

A case of factor V inhibitor

✍ Scribed by Lai-Lu Chong; Yuk-Cheung Wong

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 275 KB
Volume: 19
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830190410

No coin nor oath required. For personal study only.

✦ Synopsis

A 57-year-old married Chinese male without a family history of bleeding disorder was presented with severe hemorrhagic tendency and was subsequently found to be suffering from an acquired inhibitor against coagulation factor V. The prolonged prothrombin time and activated partial thromboplastin time could not be corrected by the addition of normal plasma. Subnormal value of factor V level was noted accompanied with an abnormal platelet factor III availability test. With specific antisera and staphylococcal protein A, the inhibitor was characterized as an IgG(1ambda) antibody. The hemorrhagic tendency and abnormal laboratory data were corrected after treating the patient with platelet concentrate transfusion and cyclophosphamide.

📜 SIMILAR VOLUMES

A case of factor V inhibitor with comple

A case of factor V inhibitor with complete correction of the PT and aPTT upon mixing

✍ Jay Lipshitz; Thandavababu Chelliah; Louis Aledort 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB 👁 1 views

Combined factor V/VIII deficiency: A cas

Combined factor V/VIII deficiency: A case report including levels of factor V and factor VIII coagulant and antigen as well as protein C inhibitor

✍ Janet M. Brown; Nancy R. Selik; Mary Jo Voelpel; Dr. Eberhard F. Mammen 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 2 views

Factor V inhibitor in thrombosis

✍ Ashok Kapur; Dr. Paul R. Kelsey; Peter E. T. Isaacs 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB

Multimodality therapy of an acquired fac

Multimodality therapy of an acquired factor V inhibitor

✍ Fu, Yang-Xin; Kaufman, Richard; Rudolph, Amy E.; Collum, Steven E.; Blinder, Mor 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Acquired inhibitors of factor V are rare causes of clinlcai bleeding, whose severity ranges from mild to iife-threatening. Optimal treatment of patients with factor V inhibitors is uncertain. We report on our successful treatment approach in a patient with spontaneous, life-threatening intracraniai

A factor V inhibitor: In vitro interfere

A factor V inhibitor: In vitro interference by calcium

✍ Macie C. Coots; Dr. Albert F. Muhleman; Helen I. Glueck 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB

## Abstract A patient with a factor V inhibitor resistant to all standard methods of therapy was recently reported. Because of this resistance, further investigation of the inhibitor was carried out employing the inhibitory plasma, serum, and isofocused fraction. It has subsequently been shown in v

Acquired factor V inhibitor complicating

Acquired factor V inhibitor complicating warfarin therapy

✍ Benjamin Gartrell 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB